We noted a tendency in B. subtilis for non-T box regulated AARS (ArgRS, AsnRS, GltRS, LysRS, MetRS, and ProRS) to charge tRNAs with amino acids encoded in mixed codon boxes (ProRS being an exception, not being encoded by a mixed codon box). This observation, together with its possible origin being a T box element that is responsive to a different tRNA, prompted us to investigate whether the T box element controlling LysRS1 expression in B. cereus Selleckchem Autophagy inhibitor might also be induced by depletion of asparaginyl-tRNAAsn. Our results show that cellular depletion of AsnRS in B. subtilis results

in induction of the P lysK(T box) lacZ. We show that this induction is not caused by concomitant depletion of lysyl-tRNALys since induction occurs when cellular levels of charged tRNALys are high (Figure 2). Importantly, there is no direct link in the biosynthetic pathways of lysine and asparagine. Also, expression of P lysK(T box) see more lacZ does not occur when cells are depleted for phenylalanine, showing that induction displays the expected specificity for lysine

starvation. These data show that the T box element controlling expression of LysRS1 of B. cereus can be induced by an increased level of uncharged tRNALys and tRNAAsn. However such Temsirolimus mw promiscuity of induction is restricted to this lysK-associated T box element since T box element control of expression of AARSs within mixed codon boxes is frequently found [17] and induction of the T box-controlled pheS, ileS and trpS genes was not observed in response to starvation for the non-cognate amino acid of the mixed codon box. The induction promiscuity of the B. cereus LysRS1-associated T box element might derive from its having evolved from a T box element that responded to a different tRNA. Such promiscuity may be tolerated since LysRS1 in B. cereus appears to have an ancillary role during stationary phase, or it may even be advantageous in that it makes LysRS1 expression responsive to a broader range of adverse nutritional

conditions. Conclusions The T box regulatory element makes expression of AARS responsive to the uncharged level of their cognate tRNA and is widely used among bacteria. However significant variability exists in the frequency with which expression of individual AARSs is controlled by this mechanism Cytidine deaminase [15–17], this study. It is largely unknown why T box regulation of LysRS expression is found in only 4 bacterial species (B. cereus, B. thuringiensis, S. thermophilum and C. beijerinckii) while more than 140 instances of T box control of IleRS expression are documented. Moreover these four bacterial species with a T box regulated LysRS all have a second non-T box regulated LysRS. We report that two tRNALys-responsive T box elements exist: the first is found in the Bacillus and Clostridium species controlling expression of a class I LysRS1 in Bacillus but a class II LysRS2 in Clostridium; the second in S.

Surprisingly, all four abundant sample-specific sequences from volunteer S3 (two see more streptococci, Granulicatella and Corynebacterium) and five of the ten abundant sample-specific sequences from volunteer S1 (three streptococci, Haemophilus and Acidovorax) were found solely in the saliva sample of the respective individuals. The relatively high abundance of these saliva-specific organisms suggests that they are a part of the commensal LY2835219 concentration oral microbiota. The most likely source of these organisms is a niche that was not specifically sampled but was exposed to saliva, e.g., tonsils, back of the tongue or subgingival

plaque. Tonsils, for instance, have been shown to harbour a more diverse community than intraoral mucosal or dental sites [15]. On average, each individual sample harboured 266 “”species-level”" phylotypes (SD 67; range

123 – 326) (Figure 6A). This is again considerably higher than the previously reported 4 – 28 species per site using traditional cloning and sequencing methods [15] or 10 – 81 species using a 16S rRNA gene-based microarray [20]. Figure 6 Diversity statistics of individual samples. Diversity statistics: A) number of taxa AZD8186 mouse (OTUs clustering sequences at a 3% genetic difference) per sampling site for each individual; B) diversity index – Shannon diversity index, H, taking into account PLEK2 the number and the proportion (abundance) of taxa. A trend for a higher diversity was observed in the samples taken at the approximal surfaces and the lingual surface of the front teeth (Figure 6B). The approximal surfaces, also known as plaque stagnations sites, are protected from regular toothbrushing. Although volunteers were asked to brush their teeth

12 hr before the samples were collected, the use of interdental oral hygiene means such as floss or toothpicks was not controlled. It is likely that older and thus more diverse plaque [21] was sampled at these sites. Higher diversity of the plaque from the lingual surface of the front tooth but not that of the molar tooth suggests that the composition of plaque of the lingual surface of the front tooth might be influenced by the anatomy of this surface – a protruding rounded tubercle at the gingival third of the crown, near the gingival sulcus. The area near the sulcus, protected by the tubercle, may have provided a niche suitable for more diverse microorganisms than anatomically flat lingual surface of the molar. The two cheek samples from individual S1 and individual S3 showed the lowest diversity among all samples (Figure 6B). These samples were dominated by only two OTUs each, identified as streptococci, with 70 sequences comprising 13% of all reads in the sample from S1, and 46 sequences comprising 17% of the reads in the cheek sample from S3.

ACS Nano 2011, 5:4329–4336.CrossRef 12. Choi KY, Min KH, Na JH, Choi K, Kim K, Park JH, Kwon IC, Jeong SY: Self-assembled hyaluronic acid nanoparticles as a potential drug carrier for cancer therapy: synthesis, characterization, and in vivo biodistribution. J Mater Chem 2009, 19:4102–4107.CrossRef 13. Cho HJ, Yoon HY, Koo H, Ko SH, Shim JS, Lee JH, Kim K, Kwon IC, Kim DD: Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic (R) for tumor-targeted delivery of docetaxel.

Biomaterials 2011, 32:7181–7190.CrossRef 14. Park learn more W, Kim KS, Bae BC, Kim YH, Na K: Cancer cell specific targeting of nanogels from acetylated hyaluronic acid with low molecular weight. Eur J Pharm Sci 2010, 40:367–375.CrossRef 15. Kamat M, El-Boubbou K, Zhu DC, Lansdell T, Lu XW, Li W, Huang XF: Hyaluronic acid immobilized magnetic nanoparticles for active targeting and imaging of macrophages. Bioconjugate Chem 2010, 21:2128–2135.CrossRef 16. Li F, Bae BC, Na K: Acetylated hyaluronic acid/photosensitizer conjugate for the preparation of nanogels with controllable phototoxicity: synthesis, characterization, autophotoquenching

properties, and in vitro phototoxicity against HeLa cells. Bioconjug Chem 2010, 21:1312–1320.CrossRef 17. Lee DE, Kim AY, Yoon HY, Choi KY, Kwon IC, Jeong SY, Park JH, Kim K: Amphiphilic hyaluronic acid-based nanoparticles for tumor-specific check details optical/MR dual imaging. J Mater Chem 2012, 22:10444–10447.CrossRef 18. Peng XH, Qian XM, Mao H, Wang AY, Chen Z, Nie SM, Shin DM: Targeted magnetic iron oxide nanoparticles for tumor imaging Cediranib (AZD2171) and therapy. Int J Nanomed 2008, 3:311–321. 19. Debouttiere PJ, Roux

S, Vocanson F, Billotey C, Beuf O, Favre-Reguillon A, Lin Y, Pellet-Rostaing S, Lamartine R, Perriat P, Tillement O: Design of gold nanoparticles for magnetic resonance imaging. Adv Funct Mater 2006, 16:2330–2339.CrossRef 20. Chen BD, Zhang H, Du N, Zhang B, Wu YL, Shi DL, Yang DR: Magnetic-fluorescent nanohybrids of carbon nanotubes coated with Eu, Gd Co-doped LaF3 as a multimodal imaging probe. J Colloid Go6983 mouse Interf Sci 2012, 367:61–66.CrossRef 21. Sun S, Zeng H, Robinson DB, Raoux S, Rice PM, Wang SX, Li G: Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. J Am Chem Soc 2004, 126:273–279.CrossRef 22. Lim EK, Kim HO, Jang E, Park J, Lee K, Suh JS, Huh YM, Haam S: Hyaluronan-modified magnetic nanoclusters for detection of CD44-overexpressing breast cancer by MR imaging. Biomaterials 2011, 32:7941–7950.CrossRef 23. Lim EK, Yang J, Suh JS, Huh YM, Haam S: Self-labeled magneto nanoprobes using tri-aminated polysorbate 80 for detection of human mesenchymal stem cells. J Mater Chem 2009, 19:8958–8963.CrossRef 24. Park J, Yang J, Lim EK, Kim E, Choi J, Ryu JK, Kim NH, Suh JS, Yook JI, Huh YM, Haam S: Anchored proteinase-targetable optomagnetic nanoprobes for molecular imaging of invasive cancer cells. Angew Chem Int Edit 2012, 51:945–948.CrossRef 25.

The phylogeny deduced from the sequence of these 2 genes evidenced two clusters

of L. borgpetersenii, one including the fully-sequenced L. borgpetersenii serovar Hardjo-bovis [26], the other one containing no reference sequence. Again, these clusters were in agreement with the clusters derived from the lfb1-based phylogeny. Interestingly, sequences from the cluster containing the Hardjo-bovis reference strain were found only in deer and none of the 88 human clinical samples evidenced this sequence. This suggests that the introduced deer C. timorensis russa might be a reservoir for this Leptospira strain. Other gene phylogenies have been studied, demonstrating that these genes might be sequenced to more precisely identify Leptospira strains, notably ligB [27], rpoB [28] and secY [8, 9, 18]. However, though they might prove useful in MLST or other NCT-501 phylogeny studies, most of them can currently only be used when sufficient amounts of DNA of the infecting strain is available, because no high-sensitivity diagnostic PCR was validated using these gene targets. However, a secY-based diagnostic PCR was recently described [9] and the sequence polymorphism of the gene segment amplified was validated as a relevant phylogenic tool [8, 9]. Therefore, we evaluated if the phylogeny of clinical specimens using this target would confirm the ones obtained

with both MLST and the lfb1 sequence polymorphism, and GM6001 nmr notably confirm and provide a more precise identification of L. interrogans clusters 2 and 3. The secY-derived phylogeny was in agreement with both the MLST and the lfb1-derived phylogenies and Ferrostatin-1 identified the same clusters (Figure 2). However, L. interrogans clusters 2 and 3 that were only evidenced by lfb1 polymorphism from clinical specimens could not be confirmed because no secY PCR product could be amplified from any of these specimens. Whether this was due to the low leptospiraemia of the corresponding patients (see Table 2) and using a different qPCR platform and different PCR reagents from Lck the ones described by Ahmed et al. [9] or to primer mismatch

in the corresponding DNAs remains unknown. Interestingly, L. interrogans cluster 5 had a secY sequence identical to L. meyeri serovar Perameles strain Bandicoot (a strain recently reassigned to the species L. interrogans [25]) and L. interrogans serovar Hardjo strain Hardjoprajitno. However, this identity was not confirmed by MLST or lfb1 sequences. Conclusions Using a combination of MLST and other sequence polymorphisms, we evidenced 7 different Leptospira genovars belonging to both L. interrogans and L. borgpetersenii. They would correspond to at least 7 strains currently circulating in New Caledonia, should two or more strains not be discriminated by this typing scheme. Within these 7 putative strains, one was presumptively identified as L.

1-VP4 was lower than antibodies obtained from mice immunized with pPG612.1-VP4-LTB and the difference was significant statistically (* P < 0.05,**P < 0.01). Results are mean values and standard errors (error bars) of triplicates. Discussion Porcine rotaviruses are the major cause of acute diarrhea in the piglets and can cause mild to severe diarrhea with potentially high morbidity and mortality

rates. Infection with porcine rotavirus has been an economic concern to worldwide pig breeders. Vaccination is the main prophylatic method for the prevention of porcine rotavirus infections. Mucosal immunization offer a number of advantages over other routes of antigen delivery, including ease of administration, cost effectiveness GSI-IX solubility dmso and the capacity of inducing both local and systemic immune responses [36–41]. To assess mucosal immune responses, specific IgA anti-VP4 protein levels were examined from various mucosal surfaces. Oral administration of recombinant VP4 or VP4-LTB-expressing L. casei induced both systemic (IgG) and mucosal (IgA) immune responses. Specifically, IgA specific for VP4 could be

isolated from the gastrointestinal tract, vagina and eye secretions compared to no detectable IgA anti-VP4 responses in control animals. These experiments suggested that L. casei expressing recombinant VP4 could be used in the vaccination of pigs, potentially protecting them from porcine rotavirus BKM120 chemical structure infections since this vector successfully elicited a significant and specific anti-VP4 IgA response. The titers of anti-VP4 IgG in the serum from mice immunized with the L. casei pPG612.1-VP4 or pPG612.1-VP4-LTB were similar but higher than the control

group. rLc393:pPG612.1-VP4-LTB induced even higher IgA specific for VP4 compared to mice immunized with the pPG612.1-VP4 as a result of the LTB mucosal adjuvant. It demonstrated the specific mucosal ATM/ATR inhibitor clinical trial adjuvanticity Chlormezanone of LTB, highlighting its potential use as a safe and effective mucosal adjuvant that can be used in conjunction with VP4 for the elicitation of specific anti-porcine rotavirus immunity. Furthermore, in order to confirm the efficacy of the induced antibodies in inhibiting the virus, we tested whether sera collected from immunized mice could inhibit the infection of RV in MA104 cells by neutralization ability assay. The results showed that serum collected from mice immunized with recombinant strains demonstrated statistically significant inhibition. The neutralization by sera antibodies obtained from mice immunized with pPG612.1-VP4-LTB was more effective than that of mice immuned with the pPG612.1-VP4. Conclusion In this report, we described the methods for constructing two L. casei recombinant expression vectors expressing the porcine rotavirus VP4 antigen or VP4-LTB fusion protein. L.

On the other hand, PAWR was highly expressed in the MCF10A cells inside the acini structure, suggesting that PAWR might have a role for the lumen acini formation. During the morphogenesis of MCF10A cells in 3D cell culture, the

cells within the lumen show apoptotic activity evidenced by caspase-3 activation. PAWR expression on this cells was only partially co-expressed with activated caspase-3. Although preliminary our results suggest that PHLDA1 and PAWR may have a role in the process of the mammary gland morphogenesis. Supported by FAPESP and CNPq. Poster No. 27 The Stem Cell Niche selleck products / Microenvironment Connectome: Mapping Transcription Factors and Signalling Networks in Normal and Pathological Conditions Rajesh Natarajan 1 1 Department of Science and Informatics, Hogent and Ghent University, Gent, East-vlanderen, Belgium Our realisation is that the stem-cell niche or microenvironment plays more than just a supporting role in tumour progression represented a radical shift in

the study of stem-cell biology. To introduce briefly, in the bone marrow, osteoblasts and endothelial cells constitutes the major cellular components contributing to the endosteal and vascular niches that serve as the microenvironment for maintaining haematopoietic stem cells (HSCs). The niche is also likely Selleck C188-9 comprised of osteoclasts and endothelial cells, fibroblasts and cancer-associated fibroblasts (CAFs), as well as adipocytes and macrophages. Although the profound influence of the stroma on tumorogenesis is now widely accepted, a full find more understanding of the cross talk between stem cells and the niche (which translates into changes in transcriptional networks and chromatin modifications), microenvironment role on heterogeneity of embryonic

and adult stem cells as well as role in development of leukaemia (LSCs) and cancer stem-cells (CSCs), remains a pheromone nascent field. In this scenario, there is an urgency to map transcriptional factors and cell signalling networks from different niches in one place, in order to exploit stem-cell niche for potential therapeutic benefits. To accomplish this goal, we are trying to apply an multidisciplinary approach to address and document molecular networks that involves in normal and in disease conditions, which is including the role of tumor initiating genes in tumor microenvironment during metastasis, small nonprotein-coding RNAs (such as microRNA pathway that differentiate LSCs from CSCs, for an example), signalling by morphogens and growth-factors (IGF1R is expressed exclusively in the hESCs, for an example) as well as functional assays (to distinguish normal HSCs from cells that have undergone some degree of neoplastic progression) and novel imaging methodologies. Hope our advanced ‘connectome- review’ initiative will eventually help us to increase quality of life for survivors of various cancers. Poster No.

Methods HBV Plasmids Five HBV 1.35-fold genome plasmids – N10 (genotype Ae, AY707087), C4371 (genotype Ba, GU357842), Y1021 (genotype C1, GU357845), Y10 (genotype D1, GU357846) and W29 (genotype I1, GU357844) were used for transfection and hydrodynamic injection. The constructions and molecular

and phenotypic characteristics are described in our previous report [36]. Z-DEVD-FMK molecular weight Bioinformatics Analysis To define the conservative sites on HBV genomes amongst the various genotypes, all available complete genome sequences Temsirolimus of HBV, as of April 2009, were downloaded from GenBank. Multiple alignment was done with ClustalX2 under default settings (Gap Opening:10, Gap Extension: 0.2, Delay Divergent Sequences(%): 30, DNA Transition Weight: 0.5, Use Negative Matrix: Off). The most representative and informative sequence in terms of phylogeny were collected as a dataset and the most similar sequences were removed using all

pairwise distance scan. A total of 327 HBV genomes including A-I genotypes and nearly all reported subtypes were remained in the final dataset. The genotypes and subtypes of six HBV genomes isolated in the study were submitted to phylogenetic analysis using MEGA 4.0 software (data not shown). Forty sites with conservative sequences were selected and the shRNA plasmids were constructed (Table 1). The designed siRNA were evaluated for potential off-target effects by the online SOS program http://​rnai.​cs.​unm.​edu/​offTarget. The sequences and positions mTOR inhibitor therapy of the forty designed shRNA targets are shown in Table 1. ShRNA Plasmids ShRNA plasmids were cloned downstream of the human H1 promoter in the vector pSUPER [37]. The target sites for siRNA were

chosen based Exoribonuclease on conservative sites among the major HBV genotypes and subtypes. An shRNA plasmid targeting the firefly luciferase gene was used as a control (L1254: TGG CTA CAT TCT GGA GAC ATA). Cell Culture and In Vitro Transfection The plasmids used for in vitro transfection were purified with PlasmidSelect Xtra Starter Kit (GE Health, Sweden) and the concentrations were determined by the UV-spectrophotometric method. To determine the ability of siRNA to inhibit HBV gene expression in cell cultures, Huh7 cells were co-transfected with 4 μg of HBV plasmids, 1 μg of shRNA plasmids and 0.4 μg of a pcDNA3.1-SEAP plasmid using Lipofectamine 2000 (Invitrogen, Shanghai, China) following the manufacturer’s instructions. They were then harvested four days later. The pcDNA3.1-SEAP plasmid is a reporter plasmid expressing secreted alkaline phosphatase and used for transfection efficiency standardization by estimating SEAP enzymatic activity (Pierce; Kunming, China) in the culture supernatant.

1 and 2. No associations between any of the pneumoprotein Wnt antagonist concentrations and exposure to endotoxins or dust were observed. The spirometric lung function variables, reported previously (Heldal et al. 2010), were not significantly associated to any of the serum concentrations of the determined pneumoproteins. Table 4

Results from multiple linear regression analysis assessing relation between pneumoproteins, (log) bacteria, and cigarette smoking (yes/no) Pneumoproteins α β Bacteria 95%CI β smoke 95%CI CC-16 (ng/ml) 3.6 0.8** 0.1–1.6 −1.6A −2.5 to 0.3 SP-D (ng/ml) 8.6 18.8** 3.5–34.1 −1.4ns U0126 price −31.5 to 28.7 Intercepts (α), regression coefficients (β), and confidence intervals (CI) are given A p = 0.11; ** p < 0.05; ns not significant Fig. 1 The univariate relationship between serum CC16 concentrations in 14 smoking (filled square) and 27 non-smoking (filled diamond) sewage workers and exposure to bacteria (CC16 = 3.6 + 0.8* log Bacteria cells, R 2 = 0.11, p < 0.05) Fig. 2 The univariate relationship between serum SP-D concentrations in 14 smoking (filled square) and 23 non-smoking (filled diamond) sewage workers and exposure to bacteria (SP-D = 8.6 + 18.8* log Bacteria cells, R 2 = 0.15, p < 0.05) Discussion The results show that the mean serum concentration

of CC16 was significantly lower with a tendency for SP-D in workers exposed to sewage dust as compared to the referents. However, the serum concentrations of CC16 and SP-D increased Tariquidar by higher personal exposure to bacterial cells sampled on the same day shortly before the collection of the blood samples. Exposure to endotoxin and dust was not associated with the pneumoproteins. No

effect of exposure on the serum concentrations of SP-A was observed. To our knowledge, pneumoprotein concentrations have only been reported in one earlier study among sewage workers. A cohort of 247 wastewater workers and 52 garbage collectors was followed up for 5 years to study respiratory health (Tchopp et al. 2011). The exposure characterization included only 11 personal exposure measurements, and only Clostridium perfringens alpha toxin exposure to endotoxins was determined. The reported concentrations seemed to be lower than in the present study (mean 52.5 EU/m3, range 7.1–158 EU/m3) (Oppliger et al. 2005). In contrast to the present study where exposure measurements and blood sampling were performed on the same day, the exposure measurements were carried out at the beginning of that study. The authors concluded that exposure to organic dust containing endotoxins did not affect the lung-specific proteins, although earlier reports from the same cohort found increased serum concentrations of CC16 and lower SP-A concentrations in asthmatics (Steiner et al. 2005; Widmeier et al. 2007). This is contradictory to the findings in the present study where lower concentrations of CC16 were observed in exposed workers and no group differences were found in the SP-A concentrations.

These studies generally indicate a ratio of 1-1.2 for maltodextrin to 0.8-1.0 fructose. For this reason, we recommend that care should be taken to consider the type of carbohydrate to ingest prior to, during, and following intense exercise in order to optimize carbohydrate availability. Protein There has been considerable debate regarding protein #CP673451 clinical trial randurls[1|1|,|CHEM1|]# needs of athletes

[27–31]. Initially, it was recommended that athletes do not need to ingest more than the RDA for protein (i.e., 0.8 to 1.0 g/kg/d for children, adolescents and adults). However, research over the last decade has indicated that athletes engaged in intense training need to ingest about two times the RDA of protein in their diet (1.5 to 2.0 g/kg/d) in order to maintain protein balance [27, 28, 30, 32, 33]. If an insufficient amount of protein is obtained from the diet, an athlete will maintain a negative nitrogen balance, which can increase protein catabolism and slow recovery. Over time, this may lead to muscle wasting and training intolerance [1,

8]. For people involved in a general fitness program, protein needs can generally be met by ingesting 0.8 – 1.0 grams/kg/day of protein. Older individuals may also benefit from a higher OICR-9429 order protein intake (e.g., 1.0 – 1.2 grams/kg/day of protein) in order to help prevent sarcopenia. It is recommended that athletes involved in moderate amounts of intense training consume 1 – 1.5 grams/kg/day of protein (50 – 225 grams/day for a 50 – 150 kg athlete) while athletes involved in high volume intense training consume 1.5 – 2.0 grams/kg/day of protein (75 – 300 grams/day for a 50 – 150 kg athlete) [34]. This protein need would be equivalent to ingesting 3 – 11 servings of chicken or fish per day for a 50 – 150 kg athlete Atezolizumab [34]. Although smaller athletes typically can ingest this amount of protein in their normal diet, larger athletes often have difficulty consuming this much dietary protein. Additionally, a number of athletic populations have been reported to be susceptible to protein malnutrition (e.g.,

runners, cyclists, swimmers, triathletes, gymnasts, dancers, skaters, wrestlers, boxers, etc). Therefore, care should be taken to ensure that athletes consume a sufficient amount of quality protein in their diet in order to maintain nitrogen balance (e.g., 1.5 – 2 grams/kg/day). However, it should be noted that not all protein is the same. Proteins differ based on the source that the protein was obtained, the amino acid profile of the protein, and the methods of processing or isolating the protein [35]. These differences influence availability of amino acids and peptides that have been reported to possess biological activity (e.g., α-lactalbumin, β-lactoglobulin, glycomacropeptides, immunoglobulins, lactoperoxidases, lactoferrin, etc).

PubMed 19. Dischert W, Vignais PM, Colbeau A: The synthesis of Rhodobacter capsulatus HupSL hydrogenase is regulated by the two-component HupT/HupR system. Mol Microbiol 1999,34(5):995–1006.PubMedCrossRef 20. Lenz O, Bernhard M, Buhrke T, Schwartz E, Friedrich B: The hydrogen-sensing apparatus in Ralstonia eutropha. J Mol click here Microbiol Biotechnol 2002,4(3):255–262.PubMed 21. Van Soom C, de Wilde P, Vanderleyden J: HoxA is a transcriptional regulator for expression of the hup structural genes in free-living Bradyrhizobium japonicum. Mol Microbiol 1997,23(5):967–977.PubMedCrossRef 22. Rey FE, Oda Y, Harwood CS: Regulation of uptake hydrogenase and effects of hydrogen utilization on

gene expression in Rhodopseudomonas palustris. J Bacteriol 2006,188(17):6143–6152.PubMedCrossRef 23. Schwartz E, Gerischer U, Friedrich B: Transcriptional regulation of Alcaligenes eutrophus hydrogenase genes. J Bacteriol 1998,180(12):3197–3204.PubMed

24. Kovacs AT, Rakhely G, Balogh J, Maroti G, Cournac L, Carrier P, Meszaros LS, Peltier G, Kovacs KL: Hydrogen independent expression of hupSL genes in Thiocapsa roseopersicina BBS. FEBS J 2005,272(18):4807–4816.PubMedCrossRef 25. Elsen S, Dischert W, Colbeau A, Bauer CE: Expression of uptake hydrogenase and molybdenum nitrogenase in Rhodobacter capsulatus is coregulated by the RegB-RegA two-component regulatory Selleckchem Ro 61-8048 system. J Bacteriol 2000,182(10):2831–2837.PubMedCrossRef 26. Martinez

M, Colombo MV, Palacios JM, Imperial J, Ruiz-Argueso T: Novel arrangement of enhancer sequences for NifA-dependent activation of the hydrogenase gene promoter in Rhizobium leguminosarum bv. viciae. J Bacteriol 2008,190(9):3185–3191.PubMedCrossRef 27. Brito B, Martinez M, Fernandez D, Rey L, Cabrera E, Palacios JM, Imperial J, Ruiz-Argueso T: Hydrogenase genes from Rhizobium leguminosarum bv. viciae are controlled by the nitrogen fixation regulatory protein nifA. Proc Natl Acad Sci USA 1997,94(12):6019–6024.PubMedCrossRef 28. Lee HS, Berger DK, Kustu S: Activity of purified NIFA, a transcriptional activator Bay 11-7085 of nitrogen fixation genes. Proc Natl Acad Sci USA 1993,90(6):2266–2270.PubMedCrossRef 29. Houchins JP, Burris RH: Occurrence and localization of two distinct hydrogenases in the heterocystous cyanobacterium Anabaena sp. selleck products strain 7120. J Bacteriol 1981,146(1):209–214.PubMed 30. Carrasco CD, Buettner JA, Golden JW: Programed DNA rearrangement of a cyanobacterial hupL gene in heterocysts. Proc Natl Acad Sci USA 1995,92(3):791–795.PubMedCrossRef 31. Axelsson R, Oxelfelt F, Lindblad P: Transcriptional regulation of Nostoc uptake hydrogenase. FEMS Microbiol Lett 1999,170(1):77–81.PubMedCrossRef 32. Happe T, Schutz K, Bohme H: Transcriptional and mutational analysis of the uptake hydrogenase of the filamentous cyanobacterium Anabaena variabilis ATCC 29413. J Bacteriol 2000,182(6):1624–1631.PubMedCrossRef 33.